AU5908473A - Creation of Inventions and Patents with Artificial Intelligence

AU5908473A – 2 and 3 substituted-4-heterocyclic amino-sulfonyl benzene sulfonamides as cerebral vasodilators
– Google Patents

AU5908473A – 2 and 3 substituted-4-heterocyclic amino-sulfonyl benzene sulfonamides as cerebral vasodilators
– Google Patents
2 and 3 substituted-4-heterocyclic amino-sulfonyl benzene sulfonamides as cerebral vasodilators

Info

Publication number
AU5908473A

AU5908473A
AU59084/73A
AU5908473A
AU5908473A
AU 5908473 A
AU5908473 A
AU 5908473A
AU 59084/73 A
AU59084/73 A
AU 59084/73A
AU 5908473 A
AU5908473 A
AU 5908473A
AU 5908473 A
AU5908473 A
AU 5908473A
Authority
AU
Australia
Prior art keywords
substituted
heterocyclic amino
cerebral vasodilators
benzene sulfonamides
sulfonyl benzene
Prior art date
1972-08-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Application number
AU59084/73A
Inventor
Peter Edward Cross
Brian Gadsby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Corp

Pfizer Inc

Original Assignee
Pfizer Corp
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1972-08-12
Filing date
1973-08-09
Publication date
1975-02-13

1973-08-09
Application filed by Pfizer Corp, Pfizer Inc
filed
Critical
Pfizer Corp

1975-02-13
Publication of AU5908473A
publication
Critical
patent/AU5908473A/en

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms

C07D295/26—Sulfur atoms

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P9/00—Drugs for disorders of the cardiovascular system

A61P9/08—Vasodilators for multiple indications

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P9/00—Drugs for disorders of the cardiovascular system

A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom

C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members

C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

C07D211/40—Oxygen atoms

C07D211/44—Oxygen atoms attached in position 4

C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom

C07D211/96—Sulfur atom

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines

C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings

C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms

C07D267/02—Seven-membered rings

C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4

C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings

C—CHEMISTRY; METALLURGY

C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR

C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES

C09B31/00—Disazo and polyazo dyes of the type A->B->C, A->B->C->D, or the like, prepared by diazotising and coupling

C09B31/02—Disazo dyes

C09B31/12—Disazo dyes from other coupling components “C”

C09B31/14—Heterocyclic components

AU59084/73A
1972-08-12
1973-08-09
2 and 3 substituted-4-heterocyclic amino-sulfonyl benzene sulfonamides as cerebral vasodilators

Expired

AU5908473A
(en)

Applications Claiming Priority (1)

Application Number
Priority Date
Filing Date
Title

GB3772072A

GB1380009A
(en)

1972-08-12
1972-08-12
Cyclic derivatives of 1,4-benzene disulphonamide

Publications (1)

Publication Number
Publication Date

AU5908473A
true

AU5908473A
(en)

1975-02-13

Family
ID=10398552
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU59084/73A
Expired

AU5908473A
(en)

1972-08-12
1973-08-09
2 and 3 substituted-4-heterocyclic amino-sulfonyl benzene sulfonamides as cerebral vasodilators

Country Status (16)

Country
Link

US
(1)

US3867390A
(en)

JP
(2)

JPS59508B2
(en)

AT
(1)

AT331248B
(en)

AU
(1)

AU5908473A
(en)

BE
(1)

BE803373A
(en)

CA
(1)

CA978945A
(en)

DE
(1)

DE2340010A1
(en)

ES
(1)

ES417806A1
(en)

FR
(1)

FR2195449B1
(en)

GB
(1)

GB1380009A
(en)

IE
(1)

IE38177B1
(en)

IN
(1)

IN139006B
(en)

LU
(1)

LU68211A1
(en)

NL
(1)

NL162641C
(en)

SE
(1)

SE385008B
(en)

ZA
(1)

ZA735474B
(en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US4070361A
(en)

1977-04-21
1978-01-24
E. R. Squibb & Sons, Inc.
Mercaptoalkylsulfonyl proline and pipecolic acid and esters thereof

DE2720654A1
(en)

1977-05-07
1978-11-16
Bayer Ag

AZOLYL ALKANOCARBONIC ACID DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS FUNGICIDES

GB1572226A
(en)

1977-11-03
1980-07-30
Hoechst Uk Ltd
Pharmaceutical preparations in solid unit dosage form

JPS5922023A
(en)

1982-07-27
1984-02-04
Hoya Corp
Beam splitter

Family Cites Families (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US3165550A
(en)

1960-06-29
1965-01-12
Pfizer & Co C
N-substituted p-benzenedisulfonamides

1972

1972-08-12
GB
GB3772072A
patent/GB1380009A/en
not_active
Expired

1973

1973-08-07
AT
AT691573A
patent/AT331248B/en
not_active
IP Right Cessation

1973-08-07
IE
IE1344/73A
patent/IE38177B1/en
unknown

1973-08-07
DE
DE19732340010
patent/DE2340010A1/en
not_active
Ceased

1973-08-08
BE
BE134373A
patent/BE803373A/en
unknown

1973-08-09
US
US386854A
patent/US3867390A/en
not_active
Expired – Lifetime

1973-08-09
NL
NL7311000.A
patent/NL162641C/en
not_active
IP Right Cessation

1973-08-09
AU
AU59084/73A
patent/AU5908473A/en
not_active
Expired

1973-08-10
FR
FR7329377A
patent/FR2195449B1/fr
not_active
Expired

1973-08-10
SE
SE7310996A
patent/SE385008B/en
unknown

1973-08-10
ZA
ZA735474A
patent/ZA735474B/en
unknown

1973-08-10
LU
LU68211A
patent/LU68211A1/xx
unknown

1973-08-10
CA
CA178,508A
patent/CA978945A/en
not_active
Expired

1973-08-11
ES
ES417806A
patent/ES417806A1/en
not_active
Expired

1973-08-11
JP
JP48090450A
patent/JPS59508B2/en
not_active
Expired

1973-08-13
IN
IN1864/CAL/73A
patent/IN139006B/en
unknown

1981

1981-07-24
JP
JP56116291A
patent/JPS5857431B2/en
not_active
Expired

Also Published As

Publication number
Publication date

NL162641C
(en)

1980-06-16

IN139006B
(en)

1976-04-24

LU68211A1
(en)

1975-05-21

NL162641B
(en)

1980-01-15

IE38177B1
(en)

1978-01-18

CA978945A
(en)

1975-12-02

AT331248B
(en)

1976-08-10

FR2195449B1
(en)

1977-09-09

DE2340010A1
(en)

1974-03-14

GB1380009A
(en)

1975-01-08

BE803373A
(en)

1974-02-08

ES417806A1
(en)

1976-03-01

JPS5857431B2
(en)

1983-12-20

NL7311000A
(en)

1974-02-14

JPS59508B2
(en)

1984-01-07

IE38177L
(en)

1974-02-12

US3867390A
(en)

1975-02-18

ZA735474B
(en)

1974-08-28

JPS57131774A
(en)

1982-08-14

JPS4985066A
(en)

1974-08-15

FR2195449A1
(en)

1974-03-08

SE385008B
(en)

1976-05-31

ATA691573A
(en)

1975-11-15

Contact information